Primary |
Product Used For Unknown Indication |
36.9% |
Haemangioma |
11.7% |
Drug Use For Unknown Indication |
10.2% |
Migraine |
5.2% |
Hypertension |
4.7% |
Prophylaxis |
4.2% |
Hyperthyroidism |
3.7% |
Supraventricular Tachycardia |
2.7% |
Thyrotoxic Crisis |
2.5% |
Anxiety |
1.7% |
Atrial Fibrillation |
1.7% |
Drug Exposure During Pregnancy |
1.7% |
Essential Tremor |
1.7% |
Hepatitis C |
1.7% |
Portal Hypertension |
1.7% |
Abnormal Behaviour |
1.5% |
Diabetes Mellitus |
1.5% |
General Anaesthesia |
1.5% |
Hepatic Cirrhosis |
1.5% |
Mitral Valve Prolapse |
1.5% |
|
Myopathy |
19.7% |
Completed Suicide |
11.6% |
Rhabdomyolysis |
8.2% |
Cardio-respiratory Arrest |
5.4% |
Circulatory Collapse |
4.1% |
Oesophageal Varices Haemorrhage |
4.1% |
Off Label Use |
4.1% |
White Blood Cell Count Increased |
4.1% |
Blood Pressure Decreased |
3.4% |
Death |
3.4% |
Hypotension |
3.4% |
Intentional Overdose |
3.4% |
Maternal Drugs Affecting Foetus |
3.4% |
Sinus Bradycardia |
3.4% |
Somnolence |
3.4% |
Toxicity To Various Agents |
3.4% |
Unresponsive To Stimuli |
3.4% |
Chest Pain |
2.7% |
Overdose |
2.7% |
Syncope |
2.7% |
|
Secondary |
Product Used For Unknown Indication |
43.0% |
Drug Use For Unknown Indication |
7.5% |
Ill-defined Disorder |
7.3% |
Haemangioma |
4.6% |
Migraine |
4.6% |
Depression |
4.0% |
Drug Exposure During Pregnancy |
4.0% |
Epilepsy |
3.3% |
Hypertension |
3.1% |
Diabetes Mellitus |
2.9% |
Bipolar Disorder |
2.2% |
Obsessive-compulsive Disorder |
1.8% |
Anxiety |
1.5% |
Blood Pressure Increased |
1.5% |
Essential Tremor |
1.5% |
General Anaesthesia |
1.5% |
Tardive Dyskinesia |
1.5% |
Abnormal Behaviour |
1.3% |
Goitre |
1.3% |
Pain |
1.3% |
|
Ventricular Septal Defect |
15.1% |
Completed Suicide |
9.3% |
Overdose |
9.3% |
Vomiting |
9.3% |
Hypoglycaemia |
5.8% |
Premature Labour |
4.7% |
Cellulitis |
3.5% |
Hypokalaemia |
3.5% |
Malaise |
3.5% |
Maternal Drugs Affecting Foetus |
3.5% |
Medication Error |
3.5% |
Migraine |
3.5% |
Multiple Drug Overdose |
3.5% |
Renal Injury |
3.5% |
Respiratory Rate Decreased |
3.5% |
Respiratory Syncytial Virus Infection |
3.5% |
Thyroid Cyst |
3.5% |
Weight Increased |
3.5% |
Bronchial Hyperreactivity |
2.3% |
Cardiac Arrest |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
14.6% |
Drug Use For Unknown Indication |
13.2% |
Hypertension |
11.5% |
Blood Pressure |
7.4% |
Hepatitis C |
6.7% |
Diabetes Mellitus |
6.4% |
Depression |
5.6% |
Pain |
4.8% |
Migraine |
4.2% |
Osteoporosis |
3.7% |
Anxiety |
3.3% |
Hiv Infection |
2.9% |
Insomnia |
2.9% |
Prophylaxis |
2.8% |
Cardiac Disorder |
1.9% |
Crohn's Disease |
1.9% |
Rheumatoid Arthritis |
1.8% |
Arthritis |
1.6% |
Swelling |
1.6% |
Schizophrenia |
1.5% |
|
Vomiting |
11.2% |
Sepsis |
7.7% |
Wrist Fracture |
6.9% |
Weight Increased |
6.6% |
Thrombocytopenia |
6.2% |
Weight Decreased |
6.2% |
White Blood Cell Count Decreased |
5.4% |
Urinary Tract Infection |
5.0% |
Pneumonia |
4.6% |
Hypertension |
4.2% |
Ventricular Septal Defect |
4.2% |
Wheezing |
4.2% |
Upper Respiratory Tract Infection |
3.9% |
Hepatic Encephalopathy |
3.5% |
Myalgia |
3.5% |
Thrombosis |
3.5% |
Type 2 Diabetes Mellitus |
3.5% |
Visual Impairment |
3.5% |
Nausea |
3.1% |
Pain |
3.1% |
|
Interacting |
Ascites |
15.1% |
Depression |
13.2% |
Schizophrenia |
11.3% |
Deep Vein Thrombosis |
7.5% |
Dyslipidaemia |
7.5% |
Hypertension |
7.5% |
Anxiety |
3.8% |
Drug Use For Unknown Indication |
3.8% |
Essential Tremor |
3.8% |
Hyperlipidaemia |
3.8% |
Pain In Extremity |
3.8% |
Rash |
3.8% |
Varices Oesophageal |
3.8% |
Fibromyalgia |
1.9% |
Influenza |
1.9% |
Migraine |
1.9% |
Migraine Prophylaxis |
1.9% |
Product Used For Unknown Indication |
1.9% |
Tremor |
1.9% |
|
Hepatic Encephalopathy |
20.0% |
Drug Interaction |
13.3% |
Dyspnoea |
13.3% |
Hypovolaemic Shock |
13.3% |
Malaise |
13.3% |
Torsade De Pointes |
13.3% |
Pituitary Tumour Benign |
6.7% |
Tremor |
6.7% |
|